Aggressive anticoagulation after TJA: An evaluation of the ACCP guidelines for thromboprophylaxis

Journal of Long-Term Effects of Medical Implants

Volumn 17, Issue 4, 2007, Pages 359-365

  Parvizi, Javad ^a,b   Kahl, Lauren K ^a   Dalsey, Chelsea ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Guidelines; Pulmonary embolism; Thromboprophylaxis

Indexed keywords

ORTHOPEDICS; PATIENT TREATMENT;

ANTICOAGULATION THERAPY; DEEP VEIN THROMBOSIS; GUIDELINES; MECHANICAL COMPRESSION; ORTHOPAEDIC SURGEONS; ORTHOPAEDIC SURGERY; PULMONARY EMBOLISM; THROMBOPROPHYLAXIS;

DISEASES;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; EPIDURAL ANESTHESIA; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MEDICAL SOCIETY; MORTALITY; PRACTICE GUIDELINE; PROSTHESIS INFECTION; REVIEW; SPINAL ANESTHESIA; SURGEON; SURGICAL INFECTION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 62449310568     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v17.i4.90     Document Type: Review

References (25)

1. Anderson FA Jr., Hirsh J, White K, Fitzgerald RH Jr. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest. 2003;124(6 Suppl):349S-56S.
2. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001;358(9275):9-15.
3. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S-400S.
4. Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest. 2003;124(6 Suppl):386S-92S.
5. Hozack WJ, Bow J. Prevention of thromboembolic disease after total hip and total knee arthroplasty in 2007: balancing the risks and benefits. US Musculoskeletal Rev. 2007;3:65-7.
6. Anon. American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. May, 18, 2007.
7. Colwell CW Jr., Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am. 1999;81:932-40.
8. Enyart JJ, Jones RJ. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery. Ann Pharmacother. 2005;39:1002-7.
9. Freedman KB, Brookenthal KR, Fitzgerald RH Jr., Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82-A:929-38.
10. Fitzgerald RH Jr., Spiro TE, Trowbridge AA, Gardiner GA Jr., Whitsett TL, O'Connell MB, Ohar JA, Young TR. Prevention of venous thromboembolic disease following primary total knee arthroplasty. a randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am. 2001;83-A:900-6.
11. Salvati EA, Pellegrini VD Jr., Sharrock NE, Lotke PA, Murray DW, Potter H, Westrich GH. Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg Am. 2000;82:252-70.
12. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22(6 Suppl 2):24-8.
13. Kim YH, Oh SH, Kim JS. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. a prospective and randomised clinical study. J Bone Joint Surg Br. 2003;85:661-5.
14. Lie SA, Engesaeter LB, Havelin LI, Furnes O, Vollset SE. Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999. Acta Orthop Scand. 2002;73:392-9.
15. Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br. 2005;87:1675-80.
16. Parvizi J, Smith EB, Pulido L, Mamelak J, Morrison WB, Purtill JJ, Rothman RH. The rise in the incidence of pulmonary embolus after joint arthroplasty: is modern imaging to blame? Clin Orthop Relat Res 2007; 463:107-13.
17. Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007;22:317-24.
18. Barcelona R. Type II heparin-induced thrombocytopenia: new treatment options. Anon. 2001. Cleveland Clinic Centre for Continuing Education Pharmacotherapy Update, July 23, 2004.
19. Menajovsky LB. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med. 2005;118 Suppl 8A:21S-30S.
20. Walenga JM, Jeske WP, Prechel MM, Bacher P, Bakhos M. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Semin Th romb Hemost. 2004;30 Suppl 1:69-80.
21. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79:1-7.
22. Davis FM, Laurenson VG, Gillespie WJ, Wells JE, Foate J, Newman E. Deep vein thrombosis after total hip replacement. A comparison between spinal and general anaesthesia. J Bone Joint Surg Br. 1989;71:181-5.
23. Dauphin A, Raymer KE, Stanton EB, Fuller HD. Comparison of general anesthesia with and without lumbar epidural for total hip arthroplasty: effects of epidural block on hip arthroplasty. J Clin Anesth. 1997;9:200-3.
24. Shaieb MD, Watson BN, Atkinson RE. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplasty. 1999;14:432-8.
25. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan CS. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172-97.